博士伦(BLCO)涨13.70% 据报公司与高盛合作考虑出售事宜

金吾财讯09-16

金吾财讯 | 博士伦(BLCO)股价走高，截止发稿，涨13.70%，报17.68美元。据知情人士透露，这家加拿大眼科护理公司正与高盛(Goldman Sachs)的顾问合作，评估买家对该公司的兴趣。该公司于2022年从鲍什健康(Bausch Health)分拆出来。知情人士透露，公司可能会吸引私募股权公司的关注，并获得相当高的溢价估值。博士伦对此表示，不会对市场传言和猜测发表评论。高盛也拒绝就此置评。

该公司计划出售之际，包括阿波罗全球管理公司(Apollo Global Management)在内的鲍什健康(Bausch Health)债权人对计划中的分拆表示担忧，因为这将对母公司的资产负债表产生影响。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2467849637?lang=zh_CN&edition=full","thumbnail":"https://static.szfiu.com/news/20210810/Yzk2MTU4OTVjMjIwMzU3MzgyMjUzNg==.jpg","is_english":false,"pubTime":"2024-09-16 22:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2467849637","market":"nz","top_or_hot":-1,"title":"博士伦(BLCO)涨13.70% 据报公司与高盛合作考虑出售事宜","media":"金吾财讯","content":"<html><body><p>金吾财讯 | <a href=\"https://laohu8.com/S/BLCO\">博士伦</a>(BLCO)股价走高，截止发稿，涨13.70%，报17.68美元。据知情人士透露，这家加拿大眼科护理公司正与<a href=\"https://laohu8.com/S/GS\">高盛</a>(Goldman Sachs)的顾问合作，评估买家对该公司的兴趣。该公司于2022年从鲍什健康(Bausch Health)分拆出来。知情人士透露，公司可能会吸引私募股权公司的关注，并获得相当高的溢价估值。博士伦对此表示，不会对市场传言和猜测发表评论。高盛也拒绝就此置评。</p><p>该公司计划出售之际，包括<a href=\"https://laohu8.com/S/APO\">阿波罗全球管理</a>公司(Apollo Global Management)在内的鲍什健康(Bausch Health)债权人对计划中的分拆表示担忧，因为这将对母公司的资产负债表产生影响。</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>博士伦(BLCO)涨13.70% 据报公司与高盛合作考虑出售事宜</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n博士伦(BLCO)涨13.70% 据报公司与高盛合作考虑出售事宜\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-16 22:40 北京时间&nbsp;&nbsp;&nbsp;<a href=279953><strong>金吾财讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>金吾财讯 | 博士伦(BLCO)股价走高，截止发稿，涨13.70%，报17.68美元。据知情人士透露，这家加拿大眼科护理公司正与高盛(Goldman Sachs)的顾问合作，评估买家对该公司的兴趣。该公司于2022年从鲍什健康(Bausch Health)分拆出来。知情人士透露，公司可能会吸引私募股权公司的关注，并获得相当高的溢价估值。博士伦对此表示，不会对市场传言和猜测发表评论。高盛也拒绝就此...</p>\n\n<a href=\"279953\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE0002270589.USD","symbol_name":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","start_time":0,"source_url":"279953","article_id":"2467849637","we_media_id":"1086022552","thumbnails":["https://static.szfiu.com/news/20210810/Yzk2MTU4OTVjMjIwMzU3MzgyMjUzNg==.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2467849637","pubTimestamp":1726497603,"sourceInfo":null,"weMediaInfo":{"media_name":"金吾财讯","introduction":"「金吾财讯」以精准用户需求为切入点，打造一站式港美股投资细分领域品牌。依托战略合作伙伴凤凰网财经，将港美股内容传播到全球华人圈。","home_visible":1,"id":"1086022552","head_image":"https://static.tigerbbs.com/19a93586c3b023ec6ebfed568990555c"},"summary":"金吾财讯 | 博士伦 股价走高，截止发稿，涨13.70%，报17.68美元。据知情人士透露，这家加拿大眼科护理公司正与高盛的顾问合作，评估买家对该公司的兴趣。该公司于2022年从鲍什健康分拆出来。博士伦对此表示，不会对市场传言和猜测发表评论。该公司计划出售之际，包括阿波罗全球管理公司在内的鲍什健康债权人对计划中的分拆表示担忧，因为这将对母公司的资产负债表产生影响。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","IE0034235188.USD":"PINEBRIDGE GLOBAL FOCUS EQUITY \"A\" (USD) ACC","BK4585":"ETF&股票定投概念","LU2237443978.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc SGD-H","LU1668664300.SGD":"Blackrock World Financials A2 SGD-H","BK4533":"AQR资本管理(全球第二大对冲基金)","LU2237443895.HKD":"abrdn SICAV I -  GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) ACC","LU2237443622.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc USD","LU2237443549.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA SGD-H","LU2237443382.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA USD","BK4588":"碎股","BK4550":"红杉资本持仓","BK4198":"医疗保健用品","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","IE0004091025.USD":"BNY MELLON GLOBAL OPPORTUNITIES \"B\" (USD) ACC","BK4552":"Archegos爆仓风波概念","IE0004086264.USD":"BNY MELLON GLOBAL OPPORTUNITIES \"A\" (USD) ACC","LU2237443465.HKD":"abrdn SICAV I -  GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) INC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","BLCO":"博士伦","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","BK4504":"桥水持仓","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","LU0106831901.USD":"贝莱德世界金融基金A2","BK4127":"投资银行业与经纪业","LU1791807156.HKD":"BGF WORLD FINANCIALS \"A2\" (HKDHDG) ACC"},"translate_title":"Bausch & Lomb (BLCO) rose 13.70%, company reportedly partnered with Goldman Sachs to consider sale","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BLCO":1},"content_text":"金吾财讯 | 博士伦(BLCO)股价走高，截止发稿，涨13.70%，报17.68美元。据知情人士透露，这家加拿大眼科护理公司正与高盛(Goldman Sachs)的顾问合作，评估买家对该公司的兴趣。该公司于2022年从鲍什健康(Bausch Health)分拆出来。知情人士透露，公司可能会吸引私募股权公司的关注，并获得相当高的溢价估值。博士伦对此表示，不会对市场传言和猜测发表评论。高盛也拒绝就此置评。该公司计划出售之际，包括阿波罗全球管理公司(Apollo Global Management)在内的鲍什健康(Bausch Health)债权人对计划中的分拆表示担忧，因为这将对母公司的资产负债表产生影响。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2467849637"}